thirty-six patients with severe aplastic anemia or acute leukemia undergoing bone marrow transplantation or intensive hematologic treatments were randomized to receive gentamicin ( 1 mg/kg/iv q8h ) or tobramycin ( 1 mg/kg/iv q8h ) in combination with carbenecillin ( 500 mg/kg/day i.v . in 4 doses ) and cephalotin ( 200 mg/kg/day i.v . in 6 doses ) , at the onset of fever during granulocytopenia .
C0005961
bone marrow transplantation
C0087111
treatments